The renal medical devices service market size has grown steadily in recent years. It will grow from $9.67 billion in 2024 to $10.1 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. Growth during the historical period was driven by an increasing incidence of chronic kidney disorders, a rising elderly population, the proliferation of dialysis centers and clinics, greater adoption of home-based dialysis, and a heightened emphasis on patient safety and device dependability.
The renal medical devices service market size is expected to see steady growth in the next few years. It will grow to $11.29 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. Key drivers in the forecast period include the advancement of home dialysis and telehealth solutions, a growing elderly population with multiple health conditions, a surge in healthcare providers outsourcing device servicing, increasing uptake of preventive and predictive maintenance strategies, and heightened participation in awareness and early detection programs. Notable trends expected include the incorporation of telemedicine and remote service capabilities, a move towards more proactive maintenance approaches, innovations in renal medical technology, the adoption of robotics and automation in servicing tasks, and tighter regulatory oversight on servicing practices.
The increasing prevalence of chronic kidney disease (CKD) is anticipated to drive the growth of the renal medical devices service market. CKD is a progressive condition in which the kidneys gradually lose their ability to filter waste products from the blood, leading to the accumulation of harmful substances in the body and potential health complications. The rise in CKD cases is largely attributed to diabetes, as elevated blood sugar levels can damage kidney blood vessels, impairing their filtering capacity. Renal medical device services play a critical role in CKD treatment by ensuring that dialysis and related equipment function optimally. These services minimize equipment downtime through timely maintenance and technical support, ultimately enhancing the reliability of treatments and improving patient care. For example, in December 2024, the Australian Institute of Health and Welfare reported that CKD accounted for approximately 22,000 deaths in 2022, with the death rate increasing from 56.7 per 100,000 in 2021 to 60.3 per 100,000 in 2022. As a result, the rising prevalence of CKD is contributing significantly to the expansion of the renal medical devices service market.
The growth in healthcare expenditure is also expected to bolster the renal medical devices service market. Healthcare expenditure encompasses the total spending on medical services, treatments, infrastructure, research, and public health programs aimed at maintaining or enhancing health outcomes. A major driver behind the increase in healthcare spending is the growing burden of chronic diseases, which require continuous treatment and management, resulting in long-term medical costs. Rising healthcare investment supports the renal medical device services sector by enabling the development and maintenance of advanced dialysis technologies. This facilitates improved access to high-quality care, enhances treatment effectiveness, and boosts patient outcomes in managing chronic kidney disease. For instance, in December 2024, the Centers for Medicare and Medicaid Services (CMS) reported that national health expenditures in the U.S. grew by 7.5% to reach $4.9 trillion in 2023, accounting for 17.6% of GDP. Furthermore, between 2023 and 2032, average annual growth in national health expenditures is projected at 5.6%, with health spending as a share of GDP expected to rise from 17.3% in 2022 to 19.7% in 2032. Consequently, increasing healthcare expenditure is a key factor driving the renal medical devices service market.
Companies operating in the renal medical devices service market are prioritizing the development of technologically advanced solutions, such as hypothermic perfusion technology, to improve organ viability and patient outcomes. Hypothermic perfusion technology is an organ preservation method in which a cold, oxygen-rich solution is circulated through donor organs at low temperatures (typically 0-12°C) to maintain viability before transplantation. For example, in January 2025, Paragonix Technologies Inc., a U.S.-based medical device firm, received FDA clearance for its KidneyVault portable renal perfusion system designed for hypothermic oxygenated perfusion of kidneys. This system preserves kidney viability during transport by utilizing hypothermic machine perfusion and SherpaCool phase-change cooling, which maintains temperatures between 4-8°C without the use of ice. Additionally, its integrated digital platform allows for real-time monitoring of temperature, pressure, flow, and resistance, enabling remote management of organ preservation.
Major players in the renal medical devices service market are Abbott Laboratories, Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co Ltd., Toray Medical Co Ltd., Boston Scientific Corporation, DaVita Inc., Terumo Corporation, Nipro Corporation, Teleflex Incorporated, ConvaTec Group Plc, Nikkiso Co Ltd., Japan Medical Supply Co Ltd., NxStage Medical Inc., B. Braun Melsungen AG, Outset Medical Inc., Rockwell Medical Inc., Quanta Dialysis Technologies Ltd., AWAK Technologies Pte Ltd., and Dialife SA.
North America was the largest region in the renal medical devices service market in 2024. The regions covered in renal medical device service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the renal medical device service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Renal medical device service refers to specialized support and maintenance services provided for equipment used in kidney care, such as dialysis machines and associated devices. The primary objective is to ensure that these machines function safely, effectively, and consistently to aid in delivering optimal patient care.
The primary categories of renal medical device services include dialysis devices, catheters, kidney monitoring devices, and kidney transplant instruments. Dialysis devices are medical tools specifically engineered to filter and cleanse the blood for patients experiencing impaired kidney function. These devices are employed in both invasive and non-invasive procedures for managing conditions like kidney failure, chronic kidney disease, end-stage renal disease, renal stones, and hypertension. Their application spans hospitals, dialysis centers, and home healthcare settings.
The renal medical devices service market research report is one of a series of new reports that provides renal medical devices service market statistics, including renal medical devices service industry global market size, regional shares, competitors with a renal medical devices service market share, renal medical devices service market segments, market trends and opportunities, and any further data you may need to thrive in the renal medical devices service industry. The renal medical devices service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The renal medical device service market includes revenues earned by entities through installation, maintenance, repair, calibration, technical support, and training services related to medical devices used in kidney care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The renal medical devices service market size is expected to see steady growth in the next few years. It will grow to $11.29 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. Key drivers in the forecast period include the advancement of home dialysis and telehealth solutions, a growing elderly population with multiple health conditions, a surge in healthcare providers outsourcing device servicing, increasing uptake of preventive and predictive maintenance strategies, and heightened participation in awareness and early detection programs. Notable trends expected include the incorporation of telemedicine and remote service capabilities, a move towards more proactive maintenance approaches, innovations in renal medical technology, the adoption of robotics and automation in servicing tasks, and tighter regulatory oversight on servicing practices.
The increasing prevalence of chronic kidney disease (CKD) is anticipated to drive the growth of the renal medical devices service market. CKD is a progressive condition in which the kidneys gradually lose their ability to filter waste products from the blood, leading to the accumulation of harmful substances in the body and potential health complications. The rise in CKD cases is largely attributed to diabetes, as elevated blood sugar levels can damage kidney blood vessels, impairing their filtering capacity. Renal medical device services play a critical role in CKD treatment by ensuring that dialysis and related equipment function optimally. These services minimize equipment downtime through timely maintenance and technical support, ultimately enhancing the reliability of treatments and improving patient care. For example, in December 2024, the Australian Institute of Health and Welfare reported that CKD accounted for approximately 22,000 deaths in 2022, with the death rate increasing from 56.7 per 100,000 in 2021 to 60.3 per 100,000 in 2022. As a result, the rising prevalence of CKD is contributing significantly to the expansion of the renal medical devices service market.
The growth in healthcare expenditure is also expected to bolster the renal medical devices service market. Healthcare expenditure encompasses the total spending on medical services, treatments, infrastructure, research, and public health programs aimed at maintaining or enhancing health outcomes. A major driver behind the increase in healthcare spending is the growing burden of chronic diseases, which require continuous treatment and management, resulting in long-term medical costs. Rising healthcare investment supports the renal medical device services sector by enabling the development and maintenance of advanced dialysis technologies. This facilitates improved access to high-quality care, enhances treatment effectiveness, and boosts patient outcomes in managing chronic kidney disease. For instance, in December 2024, the Centers for Medicare and Medicaid Services (CMS) reported that national health expenditures in the U.S. grew by 7.5% to reach $4.9 trillion in 2023, accounting for 17.6% of GDP. Furthermore, between 2023 and 2032, average annual growth in national health expenditures is projected at 5.6%, with health spending as a share of GDP expected to rise from 17.3% in 2022 to 19.7% in 2032. Consequently, increasing healthcare expenditure is a key factor driving the renal medical devices service market.
Companies operating in the renal medical devices service market are prioritizing the development of technologically advanced solutions, such as hypothermic perfusion technology, to improve organ viability and patient outcomes. Hypothermic perfusion technology is an organ preservation method in which a cold, oxygen-rich solution is circulated through donor organs at low temperatures (typically 0-12°C) to maintain viability before transplantation. For example, in January 2025, Paragonix Technologies Inc., a U.S.-based medical device firm, received FDA clearance for its KidneyVault portable renal perfusion system designed for hypothermic oxygenated perfusion of kidneys. This system preserves kidney viability during transport by utilizing hypothermic machine perfusion and SherpaCool phase-change cooling, which maintains temperatures between 4-8°C without the use of ice. Additionally, its integrated digital platform allows for real-time monitoring of temperature, pressure, flow, and resistance, enabling remote management of organ preservation.
Major players in the renal medical devices service market are Abbott Laboratories, Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co Ltd., Toray Medical Co Ltd., Boston Scientific Corporation, DaVita Inc., Terumo Corporation, Nipro Corporation, Teleflex Incorporated, ConvaTec Group Plc, Nikkiso Co Ltd., Japan Medical Supply Co Ltd., NxStage Medical Inc., B. Braun Melsungen AG, Outset Medical Inc., Rockwell Medical Inc., Quanta Dialysis Technologies Ltd., AWAK Technologies Pte Ltd., and Dialife SA.
North America was the largest region in the renal medical devices service market in 2024. The regions covered in renal medical device service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the renal medical device service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Renal medical device service refers to specialized support and maintenance services provided for equipment used in kidney care, such as dialysis machines and associated devices. The primary objective is to ensure that these machines function safely, effectively, and consistently to aid in delivering optimal patient care.
The primary categories of renal medical device services include dialysis devices, catheters, kidney monitoring devices, and kidney transplant instruments. Dialysis devices are medical tools specifically engineered to filter and cleanse the blood for patients experiencing impaired kidney function. These devices are employed in both invasive and non-invasive procedures for managing conditions like kidney failure, chronic kidney disease, end-stage renal disease, renal stones, and hypertension. Their application spans hospitals, dialysis centers, and home healthcare settings.
The renal medical devices service market research report is one of a series of new reports that provides renal medical devices service market statistics, including renal medical devices service industry global market size, regional shares, competitors with a renal medical devices service market share, renal medical devices service market segments, market trends and opportunities, and any further data you may need to thrive in the renal medical devices service industry. The renal medical devices service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The renal medical device service market includes revenues earned by entities through installation, maintenance, repair, calibration, technical support, and training services related to medical devices used in kidney care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Renal Medical Devices Service Market Characteristics3. Renal Medical Devices Service Market Trends And Strategies4. Renal Medical Devices Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market32. Global Renal Medical Devices Service Market Competitive Benchmarking And Dashboard33. Key Mergers And Acquisitions In The Renal Medical Devices Service Market34. Recent Developments In The Renal Medical Devices Service Market
5. Global Renal Medical Devices Service Growth Analysis And Strategic Analysis Framework
6. Renal Medical Devices Service Market Segmentation
7. Renal Medical Devices Service Market Regional And Country Analysis
8. Asia-Pacific Renal Medical Devices Service Market
9. China Renal Medical Devices Service Market
10. India Renal Medical Devices Service Market
11. Japan Renal Medical Devices Service Market
12. Australia Renal Medical Devices Service Market
13. Indonesia Renal Medical Devices Service Market
14. South Korea Renal Medical Devices Service Market
15. Western Europe Renal Medical Devices Service Market
16. UK Renal Medical Devices Service Market
17. Germany Renal Medical Devices Service Market
18. France Renal Medical Devices Service Market
19. Italy Renal Medical Devices Service Market
20. Spain Renal Medical Devices Service Market
21. Eastern Europe Renal Medical Devices Service Market
22. Russia Renal Medical Devices Service Market
23. North America Renal Medical Devices Service Market
24. USA Renal Medical Devices Service Market
25. Canada Renal Medical Devices Service Market
26. South America Renal Medical Devices Service Market
27. Brazil Renal Medical Devices Service Market
28. Middle East Renal Medical Devices Service Market
29. Africa Renal Medical Devices Service Market
30. Renal Medical Devices Service Market Competitive Landscape And Company Profiles
31. Renal Medical Devices Service Market Other Major And Innovative Companies
35. Renal Medical Devices Service Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Renal Medical Devices Service Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on renal medical devices service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for renal medical devices service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The renal medical devices service market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Dialysis Devices; Catheters; Kidney Monitoring Devices; Kidney Transplant Devices2) By Usage: Invasive; Non-Invasive
3) By Application: Kidney Failure; Chronic Kidney Disease; End-Stage Kidney Disease; Renal Kidney Stone Disease; Hypertension; Diabetes
4) By End User: Hospitals; Dialysis Centers; Home Healthcare
Subsegments:
1) By Dialysis Devices: Hemodialysis Machines; Peritoneal Dialysis Equipment; Dialysis Filters And Membranes; Dialysis Fluid Delivery Systems; Portable Dialysis Devices; Dialysis Consumables And Accessories2) By Catheters: Temporary Hemodialysis Catheters; Permanent Hemodialysis Catheters; Peritoneal Dialysis Catheters; Vascular Access Catheters; Central Venous Catheters For Renal Care
3) By Kidney Monitoring Devices: Creatinine Monitoring Devices; Glomerular Filtration Rate (GFR) Monitoring Devices; Blood Urea Nitrogen (BUN) Monitoring Devices; Electrolyte Monitoring Devices; Continuous Renal Function Monitors
4) By Kidney Transplant Devices: Organ Preservation Systems; Transplant Surgery Instruments; Immunosuppressant Delivery Devices; Kidney Perfusion Systems; Post-Transplant Monitoring Devices
Key Companies Profiled: Abbott Laboratories; Medtronic plc; Fresenius Medical Care AG & Co. KGaA; Asahi Kasei Medical Co Ltd.; Toray Medical Co Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Abbott Laboratories
- Medtronic plc
- Fresenius Medical Care AG & Co. KGaA
- Asahi Kasei Medical Co Ltd.
- Toray Medical Co Ltd.
- Boston Scientific Corporation
- DaVita Inc.
- Terumo Corporation
- Nipro Corporation
- Teleflex Incorporated
- ConvaTec Group Plc
- Nikkiso Co Ltd.
- Japan Medical Supply Co Ltd.
- NxStage Medical Inc.
- B. Braun Melsungen AG
- Outset Medical Inc.
- Rockwell Medical Inc.
- Quanta Dialysis Technologies Ltd.
- AWAK Technologies Pte Ltd.
- Dialife SA.
